Skip to main content

Axim Biotechnologies, Inc.

AXIM
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001514946

No open-market purchases or sales by Axim Biotechnologies, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Axim Biotechnologies, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of AXIM: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders01+1
Shares0500+500
Value$0$0$0

New holders (1)

Institutions that held Axim Biotechnologies, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to AXIM in Q3 2022
InstitutionSharesValue% of portfolio
Massmutual Trust Co FSB500$00.00%

Sold out (0)

Institutions that held Axim Biotechnologies, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

None.